Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bradbury Daniel
Relationship:   Director
City:   San Diego
State:   CA
   
Insider Summary:
  
   
Companies Owned :   8    
Direct Shares   223,469    

Indirect Shares

   3,161,475      
Direct Value   $2,427,922    

Indirect Value

   $4,299,408      
Total Shares   3,384,944      
Total Value   $6,727,329      


Paratek Pharmaceuticals Inc $79,642 Illumina Inc $1,609,480 Geron Corporation $478,300 Castle Biosciences Inc $0 Nuvation Bio Ord Shs Class A $260,500 Paratek Pharmaceuticals Inc $79,642 Illumina Inc $1,609,480 Geron Corporation $478,300 Castle Biosciences Inc $0 Nuvation Bio Ord Shs Class A $260,500
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Amylin Pharmaceuticals Inc AMLN President & Chief Exec... 2012-08-08 0 2012-08-08 0    Premium*  
            Paratek Pharmaceuticals Inc PRTK Director 2006-05-09 35,714 0    Premium*  
            Illumina Inc ILMN Director 2017-05-25 15,324 2008-05-16 0    Premium*  
            Corcept Therapeutics Inc CORT Director 2012-11-21 0 2019-02-07 130,575    Premium*  
            Geron Corporation GERN Director 2014-05-09 142,776 2019-03-29 51,323    Premium*  
            Equillium Inc EQ Chief Executive Office... 2018-10-16 0 2018-10-16 2,969,596    Premium*  
            Castle Biosciences Inc CSTL Director 2024-05-06 4,655 2024-05-06 9,981    Premium*  
            Nuvation Bio Ord Shs Class A NUVB Director 2021-02-10 25,000 2021-02-10 0    Premium*  
* Premium Members only  

Records found :    423         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 17
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
AMLN Amylin Pharmaceuticals In... Chief Operating Officer   •       –      –    2005-08-05 4 AS $20.01 $40,020 I/I (2,000) 4,481 -
AMLN Amylin Pharmaceuticals In... Chief Operating Officer   •       –      –    2005-09-08 4 AS $31.75 $63,500 I/I (2,000) 2,481 -
AMLN Amylin Pharmaceuticals In... Chief Operating Officer   •       –      –    2005-09-12 4 OE $6.88 $61,909 D/D 9,005 51,345 -
AMLN Amylin Pharmaceuticals In... Chief Operating Officer   •       –      –    2005-09-15 4 GD $0.00 $0 D/D 150 51,195 -
AMLN Amylin Pharmaceuticals In... Chief Operating Officer   •       –      –    2005-10-07 4 AS $34.75 $69,500 I/I (2,000) 481 -
AMLN Amylin Pharmaceuticals In... Chief Operating Officer   •       –      –    2005-11-07 4 AS $34.75 $69,500 I/I (2,000) 34,899 -
AMLN Amylin Pharmaceuticals In... officerTitle   •       –      –    2005-12-07 4 AS $37.20 $74,401 I/I (2,000) 32,899 -
AMLN Amylin Pharmaceuticals In... officerTitle   •       –      –    2006-01-05 4 OE $4.94 $64,056 D/D 12,972 29,268 -
AMLN Amylin Pharmaceuticals In... officerTitle   •       –      –    2006-01-09 4 AS $43.00 $86,000 D/D (2,000) 27,268 -
AMLN Amylin Pharmaceuticals In... Chief Operating Officer   •       –      –    2006-01-31 4 A $19.46 $30,827 D/D 1,332 28,600 -
AMLN Amylin Pharmaceuticals In... officerTitle   •       –      –    2006-02-07 4 AS $38.00 $76,000 D/D (2,000) 25,268 -
AMLN Amylin Pharmaceuticals In... Chief Operating Officer   •       –      –    2006-02-16 4 OE $0.78 $9,802 D/D 12,551 39,151 -
AMLN Amylin Pharmaceuticals In... Chief Operating Officer   •       –      –    2006-02-16 4 AS $38.25 $480,076 D/D (12,551) 26,600 -
AMLN Amylin Pharmaceuticals In... Chief Operating Officer   •       –      –    2006-02-21 4 OE $0.78 $9,802 D/D 12,551 39,151 -
AMLN Amylin Pharmaceuticals In... Chief Operating Officer   •       –      –    2006-02-21 4 AS $39.65 $497,647 D/D (12,551) 26,600 -
AMLN Amylin Pharmaceuticals In... Chief Operating Officer   •       –      –    2006-02-23 4 OE $0.78 $9,803 D/D 12,552 39,152 -
AMLN Amylin Pharmaceuticals In... Chief Operating Officer   •       –      –    2006-02-23 4 AS $41.00 $514,632 D/D (12,552) 26,600 -
AMLN Amylin Pharmaceuticals In... Chief Operating Officer   •       –      –    2006-03-07 4 AS $42.50 $85,000 D/D (2,000) 24,600 -
AMLN Amylin Pharmaceuticals In... Chief Operating Officer   •       –      –    2006-04-07 4 AS $46.10 $138,301 I/I (3,000) 25,907 -
AMLN Amylin Pharmaceuticals In... Chief Operating Officer   •       –      –    2006-05-05 4 AS $43.30 $129,900 I/I (3,000) 22,907 -
AMLN Amylin Pharmaceuticals In... Chief Operating Officer   •       –      –    2006-06-07 4 AS $44.45 $135,180 I/I (3,000) 19,907 -
AMLN Amylin Pharmaceuticals In... Chief Operating Officer   •       –      –    2006-07-10 4 AS $49.77 $174,297 I/I (3,500) 16,407 -
AMLN Amylin Pharmaceuticals In... Chief Operating Officer   •       –      –    2006-08-07 4 AS $47.41 $142,230 I/I (3,000) 13,407 -
AMLN Amylin Pharmaceuticals In... Chief Operating Officer   •       –      –    2006-09-08 4 AS $44.25 $93,412 I/I (2,111) 11,296 -
AMLN Amylin Pharmaceuticals In... President & Chief Operating   •       –      –    2006-10-06 4 AS $42.50 $127,500 I/I (3,000) 7,996 0 -
  423  Records found
  1   2  3   4   5   6   7   8   9   10   11   12   13   14   15   16   17      
  Page 2 of 17  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us